PLoS ONE
(Jan 2024)
Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients
- Busyamas Chewaskulyong,
- Pattarapong Satjaritanun,
- Thanika Ketpueak,
- Thatthan Suksombooncharoen,
- Chaiyut Charoentum,
- Nuttaphoom Nuchpong,
- Apichat Tantraworasin
Affiliations
- Busyamas Chewaskulyong
- Pattarapong Satjaritanun
- Thanika Ketpueak
- Thatthan Suksombooncharoen
- Chaiyut Charoentum
- Nuttaphoom Nuchpong
- Apichat Tantraworasin
- Journal volume & issue
-
Vol. 19,
no. 11
WeChat QR code